SCA practice case · Video consultation

“My pregnancy sugar test came back high — does this mean my baby’s in danger?”

The candidate brief

This is what you would read in the 3-minute window before the patient connects. Read it once, note two or three hypotheses and one thing you must not miss, then stop.

Patient
Aisha Rahman · 31 years · female
Setting
Video consultation — discussing a glucose test result in pregnancy.
Past history
  • Pregnant, 27 weeks
  • BMI 32
  • FH type 2 diabetes
Medication
  • Nil recorded
Allergies
NKDA
Recent notes
⚠ Maternity result: OGTT consistent with gestational diabetes. Letter to GP; joint clinic to contact.
Reason for contact
Video consultation: “worried about my sugar test result”.

Practise this case

The full case is in the Hot Seat with the Gold plan. You get a 12-minute timer, a role-player script with facts released only when asked, examiner checkpoints by the three RCGP domains, a model consultation and the guidance behind it.

What this case tests

Show the learning points (spoiler: read after you have practised)
GESTATIONAL DIABETES (GDM) is glucose intolerance arising in pregnancy (pregnancy hormones impairing glucose control), usually resolving after birth, with risk factors of raised BMI, family history, ethnicity and a previous large baby — so explain it simply and remove self-blame while acknowledging the mother’s fear. Give honest risk information balanced with reassurance: poorly controlled GDM raises the risk of a large baby (MACROSOMIA) and birth complications (shoulder dystocia), neonatal hypoglycaemia, polyhydramnios, pre-eclampsia and increased intervention/Caesarean, with longer-term type 2 diabetes risk for mother and child — but GOOD GLUCOSE CONTROL substantially REDUCES these risks, so the anchoring message is "manageable, and controlling it protects your baby", not catastrophe. Management: referral to the JOINT antenatal/diabetes (maternal medicine) team within 1 week (NICE NG3), blood glucose self-monitoring against targets (fasting below 5.3 mmol/L; 1 hour after meals below 7.8 or 2 hours below 6.4 mmol/L), diet and physical activity first-line (dietitian input), and metformin if targets are not met within 1–2 weeks, then insulin (immediate insulin if fasting glucose is 7.0 mmol/L or more at diagnosis) — metformin and/or insulin if targets are not met (reassuring these are safe in pregnancy). Explain increased fetal monitoring (growth and amniotic fluid scans every 4 weeks from 28 to 36 weeks for macrosomia/polyhydramnios) and that delivery is planned by the team (timing and place per glycaemic control and fetal size, usually avoiding prolonged pregnancy — no later than 40+6 weeks if uncomplicated). Postnatally, glucose usually normalises but needs a postnatal check (fasting plasma glucose at 6–13 weeks; HbA1c only after 13 weeks if a fasting test is not possible), with lifelong increased type 2 diabetes risk (annual HbA1c, NICE QS109; lifestyle), likely recurrence in future pregnancies (early self-monitoring or OGTT next time), higher long-term metabolic risk for the child, and breastfeeding encouraged. The communication core (and hidden agenda) is fear for the baby and self-blame; give accurate risk information WITHOUT catastrophising, repeatedly anchor on the reassuring controllable message, remove blame, check understanding, and provide a concrete next step so she leaves informed and supported.

The guidance behind it

Similar SCA cases

Browse all 359 cases by experience group →

gpreasoning.uk is not affiliated with or endorsed by the RCGP. Our cases are original teaching material written for practice; none is an exam recall. For anything official about the SCA, check the RCGP SCA pages.